Clinical Prostate CancerBahn DK, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer. 2003;2(2):111–4.Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A, et al. Salvage cryosurgery for recurrent prostate...
Prostate cancer is a major cause of cancer morbidity and mortality. Intra-prostatic inflammation is a risk factor for prostate carcinogenesis, with diet, chemical injury and an altered microbiome being causally implicated. Intra-prostatic inflammatory ce
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.
Re: Survival after Conservative Management versus External Beam Radiation Therapy in Elderly Patients with Localized Prostate CancerProstate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate ... Griebling,L Tomas - 《Journal of Urology》 被引量: 0...
2025 Bone Pain and Survival Outcomes for Metastatic, Hormone-Sensitive Prostate Cancer Research July 9, 2024 ADT and Outcomes After Radiation Therapy Among Black Patients With Prostate Cancer Research June 10, 2024 Sign Up for Emails Based on Your Interests Others Also Liked We recommend Uranium res...
The improved survival was observed for ages 50 years or older, both White patients and Black patients, all tumour stages and grades. This was also demonstrated despite the receipt of surgery or radiation treatment. Conclusions MHS beneficiaries with advanced prostate cancer had longer survival than ...
[10]. Loss of the membrane protein caveolin-1 in CAFs is associated with radiation resistance of prostate cancer cells and thus affects disease prognosis [11,12]. Considering that disease recurrence remains high after initial radiotherapy, it is still urgent to explore the important CAF-related ...
Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience Objectives. Cryotherapy of the prostate represents a potential treatment for localized recurrent prostate cancer after radiation therapy. We report our exp... ADL Taille,O Hayek,MC Benson,... - 《Urology...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of these; also systematic reanalysis of public miR-profile...
Nearly one-third of patients with prostate cancer (PCa) experience biochemical recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant metastasis and mortality in patients with prognostically unfavorable features. These patients are best managed with a tailored treatment str...